The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Efficacy and safety of HLX43 (an anti–PD-L1 ADC) in previously treated recurrent/metastatic nasopharyngeal carcinoma: A multicenter, randomized phase 2 study.
 
Jun Ma
Research Funding - Bristol Myers Squibb Foundation; Varian Medical Systems
 
Ye-Lin Liang
No Relationships to Disclose
 
Yi Xia
No Relationships to Disclose
 
Yan-Qun Xiang
No Relationships to Disclose
 
Peng Zhang
No Relationships to Disclose
 
Liangfang Shen
No Relationships to Disclose
 
Xiaozhong Chen
No Relationships to Disclose
 
Kunyu Yang
No Relationships to Disclose
 
Zhigang Liu
No Relationships to Disclose
 
Qingqing Cai
No Relationships to Disclose
 
Hao-Yuan Mo
No Relationships to Disclose
 
Song Qu
No Relationships to Disclose
 
Mingjun Xu
No Relationships to Disclose
 
Chuanben Chen
No Relationships to Disclose
 
Fan Zhang
Employment - Shanghai Henlius Biotech
 
Xiaoli Hou
Employment - Shanghai Henlius Biotech
 
Haoyu Yu
Employment - Shanghai Henlius Biotech
 
Jing Li
Employment - Shanghai Henlius Biotech
 
Qingyu Wang
Employment - Shanghai Henlius Biotech
 
Jun Zhu
Employment - Shanghai Henlius Biotech